Covaxin phase 2 trial results show better reactogenicity, safety: Lancet study


India Today | Latest Stories
https://ift.tt/30oHI0S
Covaxin phase 2 trial results show better reactogenicity, safety: Lancet study
March 09, 2021 at 11:13AM

Comments